Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

JOHN J PEET

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1477641322
CMS profile
66641
Location
THE WOODLANDS, TX

General Payments · PY2019–2025

$5,063.37

  • Reported across 152 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$366.20

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $366.20 15

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $409.80 22
PY2020 $1,263.87 18
PY2021 $1,019.38 33
PY2022 $1,114.21 34
PY2023 $453.44 19
PY2024 $436.47 11
PY2025 $366.20 15

Payment records · PY2025 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Acella Pharmaceuticals, LLC $23.70 02/18/2025 Food and Beverage Undisputed 06/30/2026 1241765974 CMS
Astellas Pharma US Inc $33.70 09/29/2025 Food and Beverage Undisputed 06/30/2026 1238681031 CMS
Dexcom, Inc. $18.48 05/05/2025 Food and Beverage Undisputed 06/30/2026 1250495244 CMS
Galderma Laboratories, L.P. $64.51 03/20/2025 Food and Beverage Undisputed 06/30/2026 1234689151 CMS
Galderma Laboratories, L.P. $21.75 04/29/2025 Food and Beverage Undisputed 06/30/2026 1234689153 CMS
Galderma Laboratories, L.P. $11.41 07/31/2025 Food and Beverage Undisputed 06/30/2026 1234689155 CMS
Galderma Laboratories, L.P. $8.38 08/01/2025 Food and Beverage Undisputed 06/30/2026 1234689157 CMS
Galderma Laboratories, L.P. $8.66 09/11/2025 Food and Beverage Undisputed 06/30/2026 1234689159 CMS
Galderma Laboratories, L.P. $10.38 10/15/2025 Food and Beverage Undisputed 06/30/2026 1234689161 CMS
Galderma Laboratories, L.P. $12.85 10/23/2025 Food and Beverage Undisputed 06/30/2026 1234689163 CMS
Galderma Laboratories, L.P. $4.56 12/19/2025 Food and Beverage Undisputed 06/30/2026 1234689165 CMS
Hologic Sales and Service, LLC $24.32 03/24/2025 Food and Beverage Undisputed 06/30/2026 1182640271 CMS
Hologic Sales and Service, LLC $31.07 07/23/2025 Food and Beverage Undisputed 06/30/2026 1182640421 CMS
REVANCE THERAPEUTICS, INC. $48.11 03/19/2025 Food and Beverage Undisputed 06/30/2026 1251170829 CMS
REVANCE THERAPEUTICS, INC. $44.32 09/23/2025 Food and Beverage Undisputed 06/30/2026 1251170831 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.